The epidemiology and control of hepatitis C infection.
Hepatitis C is a global public health problem, and a major cause of chronic hepatitis. The virus can cause cirrhosis, liver failure and primary liver cancer. Combination therapy is effective in 50-60 per cent of patients with chronic infection. Prevention initiatives should target high-risk groups, such as injecting drug users.
D000998:Antiviral Agents / Q000627:therapeutic use*; D018562:Disease Transmission, Infectious; D006526:Hepatitis C / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control*; D006801:Humans; D015994:Incidence; D016898:Interferon-alpha / Q000627:therapeutic use*; D011159:Population Surveillance; D015995:Prevalence; D012254:Ribavirin / Q000627:therapeutic use*; D012307:Risk Factors
D000998:Antiviral Agents; D016898:Interferon-alpha; D012254:Ribavirin